Skip to Main Content

Author Details

Alykhan F Shamji
Center for the Science of Therapeutics, Broad Institute
1999
58
40
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34124936The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4<sup>+</sup> T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.Mol Cell Biol2021
34124936The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4<sup>+</sup> T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.Mol Cell Biol2021
31461650Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors.Cell Rep2019
31461650Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors.Cell Rep2019
30046103Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROS.Nature2018
30046103Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROS.Nature2018
28805801Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells.Nat Chem Biol2017
28678785Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.Nature2017
28805801Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells.Nat Chem Biol2017
28327978A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay.Gigascience2017
29073062Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.Proc Natl Acad Sci U S A2017
29195078A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.Cell2017
28327978A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay.Gigascience2017
29195078A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.Cell2017
29073062Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.Proc Natl Acad Sci U S A2017
28678785Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.Nature2017
27109210A genetic basis for the variation in the vulnerability of cancer to DNA damage.Nat Commun2016
27109210A genetic basis for the variation in the vulnerability of cancer to DNA damage.Nat Commun2016
26928769High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.Nat Biotechnol2016
27012813DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.Clin Cancer Res2016
27329820Integrated genetic and pharmacologic interrogation of rare cancers.Nat Commun2016
27224444Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo.ACS Chem Biol2016
26656090Correlating chemical sensitivity and basal gene expression reveals mechanism of action.Nat Chem Biol2016
26656089Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.Nat Chem Biol2016
27774134Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1.ACS Med Chem Lett2016
26656090Correlating chemical sensitivity and basal gene expression reveals mechanism of action.Nat Chem Biol2016
26656089Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.Nat Chem Biol2016
27774134Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1.ACS Med Chem Lett2016
27329820Integrated genetic and pharmacologic interrogation of rare cancers.Nat Commun2016
27224444Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo.ACS Chem Biol2016
27012813DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.Clin Cancer Res2016
26928769High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.Nat Biotechnol2016
25501949Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.Cancer Discov2015
25501949Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.Cancer Discov2015
25660025Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.Cell Rep2015
25860544Discovery of a Small-Molecule Probe for V-ATPase Function.J Am Chem Soc2015
25968887KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.Cancer Res2015
26482930Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.Cancer Discov2015
26046436Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.Cell2015
25998054The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells.Elife2015
26375002Corrigendum: Selective killing of cancer cells by a small molecule targeting the stress response to ROS.Nature2015
26195741Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics.Proc Natl Acad Sci U S A2015
26488816Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation.Immunity2015
26488816Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation.Immunity2015
26482930Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.Cancer Discov2015
26375002Corrigendum: Selective killing of cancer cells by a small molecule targeting the stress response to ROS.Nature2015
26046436Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.Cell2015
26195741Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics.Proc Natl Acad Sci U S A2015
25860544Discovery of a Small-Molecule Probe for V-ATPase Function.J Am Chem Soc2015
25968887KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.Cancer Res2015
  • 1 - 50 of 116

Recommended Authors

Institute of Experimental Medicine and Systems Biology, RWTH Aachen University
Career Start Year 2016
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Friedrich Miescher Institute for Biomedical Research
Career Start Year 2010
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 2009
Number of shared co-authors 3
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2007
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 2004
Number of shared co-authors 2
University of Southern California
Career Start Year 2004
Number of shared co-authors 1
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2003
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 2
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 6
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 8
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 6
University of Toronto, College St
Career Start Year 1999
Number of shared co-authors 3
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 11
Institute for Data Science and Computing, University of Miami
Career Start Year 1998
Number of shared co-authors 9
University of Toronto
Career Start Year 1997
Number of shared co-authors 7
Stanford University Medical Center
Career Start Year 1997
Number of shared co-authors 8
Genomics Institute of the Novartis Research Foundation
Career Start Year 1997
Number of shared co-authors 8
University of California san francisco
Career Start Year 1996
Number of shared co-authors 5
Sirna Therapeutics a former subsidiary of Merck & Co., Inc.
Career Start Year 1994
Number of shared co-authors 2
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 9
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 5
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Career Start Year 1990
Number of shared co-authors 24
Institute of Pharmaceutical Chemistry, Goethe University
Career Start Year 1983
Number of shared co-authors 5

Collaborators

Broad Institute
Co-authored papers 55
Broad Institute
Co-authored papers 27
Broad Institute
Co-authored papers 14
Broad Institute of MIT and Harvard
Co-authored papers 14
Co-authored papers 13
Broad Institute of MIT and Harvard
Co-authored papers 11
Co-authored papers 10
Johns Hopkins University School of Medicine
Co-authored papers 10
Co-authored papers 8
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 6
Cutaneous Biology Research Center
Co-authored papers 6
University of California San Diego
Co-authored papers 5
Harvard Medical School
Co-authored papers 5
Broad Institute of MIT and Harvard
Co-authored papers 5
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 4
Broad Institute of Harvard and MIT
Co-authored papers 4
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Co-authored papers 4
Broad Institute of MIT and Harvard
Co-authored papers 4
Columbia University
Co-authored papers 4
Co-authored papers 4
Massachusetts General Hospital
Co-authored papers 4
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 4
Broad Institute of Harvard and MIT
Co-authored papers 4
Co-authored papers 4
Broad Institute of Harvard and MIT
Co-authored papers 3
Co-authored papers 3
Moores Cancer Center, University of California San Diego
Co-authored papers 3
Co-authored papers 3
Janssen Research and Development LLC
Co-authored papers 3
Co-authored papers 3